chr11-765037-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006755.2(TALDO1):c.*192G>A variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00587 in 707,282 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 76 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 40 hom. )
Consequence
TALDO1
NM_006755.2 downstream_gene
NM_006755.2 downstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.39
Publications
1 publications found
Genes affected
TALDO1 (HGNC:11559): (transaldolase 1) Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008]
TALDO1 Gene-Disease associations (from GenCC):
- transaldolase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-765037-G-A is Benign according to our data. Variant chr11-765037-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 368974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0601 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TALDO1 | NM_006755.2 | c.*192G>A | downstream_gene_variant | ENST00000319006.8 | NP_006746.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TALDO1 | ENST00000319006.8 | c.*192G>A | downstream_gene_variant | 1 | NM_006755.2 | ENSP00000321259.3 | ||||
| TALDO1 | ENST00000528097.5 | c.*245G>A | downstream_gene_variant | 1 | ENSP00000437098.1 | |||||
| TALDO1 | ENST00000530666.1 | n.*90G>A | downstream_gene_variant | 2 | ||||||
| TALDO1 | ENST00000532202.1 | n.*32G>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0178 AC: 2704AN: 152092Hom.: 74 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2704
AN:
152092
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00258 AC: 1434AN: 555072Hom.: 40 Cov.: 7 AF XY: 0.00217 AC XY: 640AN XY: 294760 show subpopulations
GnomAD4 exome
AF:
AC:
1434
AN:
555072
Hom.:
Cov.:
7
AF XY:
AC XY:
640
AN XY:
294760
show subpopulations
African (AFR)
AF:
AC:
988
AN:
15530
American (AMR)
AF:
AC:
105
AN:
31736
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
17284
East Asian (EAS)
AF:
AC:
0
AN:
31190
South Asian (SAS)
AF:
AC:
18
AN:
56048
European-Finnish (FIN)
AF:
AC:
6
AN:
30850
Middle Eastern (MID)
AF:
AC:
4
AN:
2322
European-Non Finnish (NFE)
AF:
AC:
117
AN:
340106
Other (OTH)
AF:
AC:
196
AN:
30006
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
62
124
186
248
310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0179 AC: 2717AN: 152210Hom.: 76 Cov.: 33 AF XY: 0.0174 AC XY: 1297AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
2717
AN:
152210
Hom.:
Cov.:
33
AF XY:
AC XY:
1297
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
2578
AN:
41506
American (AMR)
AF:
AC:
78
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5182
South Asian (SAS)
AF:
AC:
4
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23
AN:
68020
Other (OTH)
AF:
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
133
266
400
533
666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Deficiency of transaldolase Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.